Related Experiment Video
Updated: Jan 14, 2026

09:20
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
8.8K
Characterizing chlorotriazine effects in cancer-relevant high-throughput screening assays
Agnes L Karmaus1, Alex Charlton1
1Syngenta Crop Protection, LLC, Greensboro, NC, United States.
Frontiers in Toxicology
|October 20, 2025
Summary
High-throughput screening (HTS) identified potential cancer-related bioactivity in chlorotriazine herbicides by analyzing ToxCast/Tox21 data. Integrating in vitro results with in vivo evidence provides a framework for assessing carcinogenicity.
Area of Science:
- Toxicology
- In vitro screening
- Chemical risk assessment
Background:
- High-throughput screening (HTS) in vitro testing offers a powerful method for evaluating numerous chemicals across diverse mechanistic assays.
- Carcinogenesis research benefits from systematic evaluation of HTS in vitro data for relevant endpoints.
- The ToxCast/Tox21 HTS program provides assay endpoints mapped to Key Characteristics of Carcinogens (KCCs), aiding in the identification of potential carcinogenicity mechanisms.
Purpose of the Study:
- To review HTS in vitro data from the ToxCast/Tox21 program for five chlorotriazine herbicides.
- To evaluate potential cancer-relevant bioactivity using KCC-mapped assay endpoints.
- To demonstrate a workflow integrating in vitro mechanistic data with toxicokinetic and in vivo evidence for carcinogenicity assessment.
Main Methods:
- Retrieved ToxCast/Tox21 HTS assay endpoint data from invitrodb v4.2 for five chlorotriazine herbicides.
- Focused the review on assay endpoints mapped to KCCs, identifying approximately 750 potentially informative assays.
- Integrated assay flags for robust bioactivity and contextualized in vitro findings with literature-based toxicokinetics and in vivo data.
Main Results:
- Common bioactive targets across the chlorotriazine herbicide class included induction of estrone levels and potential CAR/PXR activation.
- In vitro findings were contextualized using in vivo data and specific knowledge of atrazine.
- The HTS mechanistic assays did not reveal novel insights into chlorotriazine carcinogenicity but demonstrated workflow utility.
Conclusions:
- The developed workflow exemplifies integrating mechanistic screening data with apical endpoints for chemical class review.
- Contextualizing in vitro ToxCast/Tox21 data with toxicokinetics and in vivo outcomes is crucial for robust carcinogenicity assessment.
- The KCC framework, combined with HTS data and toxicokinetic information, provides a systematic approach to evaluating chemical carcinogenicity potential.

